Botanical drugs and supplements affecting the immune response in the time of <scp>COVID</scp>‐19: Implications for research and clinical practice
Thomas Brendler(Immanuel Krankenhaus), Elizabeth M. Williamson(University of Reading), Rudolf Bauer(University of Graz), Stefan Gafner(Botanical Society of America), Michael Heinrich(China Medical University), Martin Michaelis(University of Kent), Ahmed Al‐Harrasi(University of Nizwa), Angelo A. Izzo(University of Naples Federico II), Marjan Nassiri‐Asl(Shahid Beheshti University of Medical Sciences), Mary Hardy(Integrative Medicine Institute), Alexander Panossian(Sandvik (Sweden)), Solomon P. Wasser(University of Haifa), Hossein Hosseinzadeh(Mashhad University of Medical Sciences)
Cited by 106
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy
|Phytomedicine|2010|594
Best practice in research – Overcoming common challenges in phytopharmacological research
|Journal of Ethnopharmacology|2019|548
Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine
|Journal of Ethnopharmacology|2008|521
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
|European Neuropsychopharmacology|2011|465